Troleandomycin (TAO)

01/01/1992 - "To investigate the efficacy of magnetic resonance imaging (MRI) in the assessment of thyroid-associated ophthalmopathy (TAO), 51 patients with TAO were evaluated by ophthalmologic examinations and MRI at 0.5 T. "
10/19/2023 - "This study used swept-source optical coherence tomography (SS-OCT) to investigate subfoveal choroidal thickness (SFCT) in patients with thyroid-associated ophthalmopathy (TAO) who displayed different levels of disease activity and severity. "
08/22/2023 - "This study aimed to evaluate corneal morphological and biomechanical changes in patients with thyroid-associated ophthalmopathy (TAO) and their correlations with activity and severity. "
01/01/2023 - "This study was designed to investigate the association between fibulin-1(FBLN1) and thyroid-associated ophthalmopathy (TAO). "
01/01/2023 - "The study included 40 patients (75 orbits) with thyroid eye disease (TED; also termed Graves' ophthalmopathy, GO; thyroid-associated orbitopathy, TAO), who were divided into three groups depending on the method of surgical treatment. "

10/22/2021 - "Currently, there is no consensus regarding the best treatment for patients with thromboangiitis obliterans (TAO). "
01/01/1983 - "The long-term follow-up of 19 cases with thromboangitis obliterans (TAO) (20 limbs) revealed excellent results in 62%, good results in 19% and poor results in 19%. "
01/20/2020 - "To date, there is no effective treatment for thromboangiitis obliterans (TAO). "
10/01/2020 - "Few studies used nationwide data to assess the age-standardized prevalence rate, incidence rate, 10-year survival rate, and death risk of thromboangiitis obliterans (TAO; Buerger's disease). "
06/01/2019 - "The aim of the study was to evaluate the technical success of the procedure and the clinical efficacy of treatment in patients with thromboangiitis obliterans (TAO) (Buerger's disease) based on a change in the Rutherford classification. "

10/01/2019 - "Our aim was to identify new loci interacting with ELTS exposure on time-to-asthma onset (TAO) in childhood. "
10/01/2016 - "We conducted a large-scale meta-analysis of 9 genome-wide association studies of TAO (total of 5462 asthmatic patients with a broad range of age of asthma onset and 8424 control subjects of European ancestry) performed by using survival analysis techniques. "
10/01/2016 - "We sought to identify the genetic variants associated with time to asthma onset (TAO). "
11/01/1993 - "Troleandomycin in the treatment of difficult asthma."
05/01/1961 - "Infectious asthma treated with triacetyloleandomycin."

05/01/2017 - "Proportions of SSC-treated (7/8) or HNE-treated (5/8) wounds needing EGT excision were significantly greater than that of TAO-treated (1/8) wounds. "
06/01/2020 - "Mice were exposed to sonication-induced trauma as described previously (by Tao et al) and optic nerves were harvested at 1, 7, or 14 days following injury [4]. "
10/01/2018 - "Our data showed that WIRS-exposed mice produced several injuries and showed an enhanced iNOS, reduced eNOS activity, and decreased TAO activity in the stomach, whereas pretreatment with big-leaf mulberry extracts increased TAO activitiy. "
03/31/2018 - "Ninety-seven patients with TAO with ischaemic wounds treated between January 2007 and July 2016 were included in this dual-centre, non-randomised, retrospective study. "
05/01/2017 - "Least squares mean microbial counts were significantly higher for HNE-treated wounds on days 9 and 21, compared with SSC-treated and TAO-treated wounds, but not controls. "

03/01/2015 - "Extraocular muscle inflammation in TAO improved with treatment. "
07/01/2023 - "In summary, this study provides the first evidence that LU significantly attenuates the pathogenic manifestations of TAO by inhibiting the expression of fibrotic and inflammation-related genes and ROS produced by OFs. "
01/01/2022 - "Our study shows that lipofibroblasts with RASD1 expression are highly involved in inflammation and adipogenesis during TAO. "
01/01/2022 - "Our study demonstrates that the orbital immune tolerance deficiency caused by the lack of PD-L1 in orbital fibroblasts may be one of the causes for the active orbital inflammation in TAO patients, and the utilization of exogenous PD-L1 to reconstruct the orbital immune tolerance microenvironment may be a potential treatment strategy for TAO."
07/20/2020 - "In summary, the present study elucidates that SP may suppress inflammation and proliferation and promote apoptosis through the PI3K-AKT pathway, which makes SP a potential treatment against TAO. "